Society for. Coalition. May 1, Research. the Food. information. In 1999, meet the. May 1, 2009 SWHR 1
|
|
- Dominic Carr
- 5 years ago
- Views:
Transcription
1 Written Testimony By: Phyllis Greenberger, MSW: President and CEO, Society for Women s Health Research and Jeanne Becker, Ph.D.: Chair, Women s Health Research Coalition Before the House Appropriations Committee, Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies May 1, 2009 Submitted for the Record On the behalf of the Society for Women s Health Research and the Women s Health Research Coalition, we are pleased to submit testimony in support of increased funding for the Food and Drug Administrati ion (FDA), and more specifically for the Office of Women s Health (OWH), a critical focal point on women s healthh within the Agency. The Society for Women's Health Research is the nation s only non-profit organization whose mission is to improve the healthh of all women throughh advocacy, research, and education. Founded in 1990, the Society brought to national attention the need for the appropriate inclusionn of women in major medical research studies and the need for more information about conditions affecting women exclusively, disproportionately, or differently than men. The Society advocates increased funding for research on women s health; encourages the study of sex differences that may affect the prevention, diagnosiss and treatment of disease; promotes the inclusion of women in medical research studies; and informs women, providers, policy makers and media about contemporary women s health issues. In 1999, the Women s Health Research Coalition was established by the Society to give a voice to scientists and researchers from across the country that are concerned and committed to improving women s health research. The Coalition now has more than 650 members, including leaders within the scientific community and medical researchers from many of the country s leading universities and medical centers, as well as leading voluntary health associations, and pharmaceutical and biotechnology companies. The Society and the Coalition are committed to advancing the health status of women through the discovery of new and useful scientific knowledge. We strongly believe that appropriate funding of the FDA by Congress is critical for the Agency to function and to assure the American public of the safety of its food and drugs. However, as has been well documented, currently the FDA is endeavoring to catch up after years of flat funding to meet the needs of scientific growth, innovation and development, and adequate food and drug protection. Further, FDA is struggling to catch up to present-day needs in the area of information technology (IT). Last year the FDA was awardedd a $325 million dollar increase to assist in revamping the Agency, as well as a one time investment of $150 million in supplemental funding. This influx of funds was meant to address years of chronic under-funding; however, the Agency needs a continuous stream of funding to address the myriad of infrastructure, resourcess and IT issuess resulting from the budget shortages it has faced in the past decade. The Society urges Congress to provide the FDA with an increase of $386 million, bringing the FDA s FY 2010 budget to $2.425 billion. This funding increasee will allow the FDA to May 1, 2009 SWHR 1
2 continue rebuilding its infrastructure and addressing the shortage of resources was well as install IT systems that match the needs of the industries it is regulating and expectations of the American public. Another important investment that must be taken into account at the FDA is the Office of Women s Health (OWH). OWH s women s health programs, often conducted with the Agency centers, are vital to maintaining focus on women s health within the FDA. They are critical to improved care and increased awareness of disease-specific impacts to women. For example, OWH ensures that sex and gender differences in the efficacy of drugs (such as metabolism rates), devices (sizes and functionality) and diagnostics are taken into consideration in reviews. To address OWH s growing list of priorities, the Society recommends that Congress support a $7 million budget for OWH for FY 2010 within the budget for the FDA. In addition, we further recommend that the current budget levels not only increase in the future, but should never be less than the $6 million that the office currently receives. FDA Information Technology Systems The FDA is tasked with guarding the safety, efficacy, and security of human drugs, biological products, and medical devices. However, as was stated by the Science Board Report, requested by former Commissioner von Eschenbach, FDA s IT systems were inefficient and incapable of handling the current demands placed on the Agency, thus preventing the FDA from fulfilling its mission. Equipment is outdated, often unsupported by maintenance, and regularly breaks down. FDA s IT system, a system which needs to function 24/7, simply cannot keep up with current scientific data and market trends. This will only continue to worsen as servers age beyond usefulness, and serviceability and networks fail multiple times per day. Additionally, the new Obama Administration is seeking to pass an overhaul of the nation s healthcare system. This reform is likely to include further advances to electronic health records and other IT innovations which will place an even greater burden on the FDA, among other agencies, to function within those advanced IT systems and networks. The antiquated nature of the IT systems also makes the agency unable to conduct safety analyses for product marketing applications, track the natural history and disease models for rare disorders, and access huge amounts of clinical data. The creation of a central database must happen to provide for a system query to a centralized repository for all relevant facts about a certain product including where, when and how the product was made. Such a uniform centralized database will be relevant for all information stored across agencies, so as to maximize functionality not only of FDA s data but of expected research and analysis needed by the American public. Currently, the FDA receives large volumes of information in applications from drug manufacturers for review and evaluation. FDA reviewers must manually comb through the submitted drug trial reports and digital data in as many as twelve formats to evaluate a new drug's safety and effectiveness. Frequently reviewers must handpick data manually from stacks of paper reports and craft their own data comparisons. This process is time consuming, makes the review process less efficient, and is error-prone and delays access to important information. Scientific and medical advances are occurring rapidly and the public needs and deserves access to the most recent and accurate information regarding their health. It is time Congress recognize that the Agency must utilize up-to-date information technology and that it sorely needs the resources to maintain them. May 1, 2009 SWHR 2
3 The Society believes that the Agency and/or the FDA s Office of Women s Health should be able to track women or men and other subpopulations in all clinical trials before them and they are currently not able to do so. The FDA should be able to know how many women are in studies (both by recruitment and retention rates). This should be an immediate goal of any new IT system upgrade at the Agency in conjunction with the adoption of uniform data standards from which to pull the data and as part of the shift to an automated, electronic filing system. Estimations have shown that it would take $200 million ($40 million/year) over the course of 5 years to begin the process of improving the IT system. Congress must address past shortfalls to FDA and provide it a $386 million increase to begin IT transformation and many other improvements. Office of Women s Health OWH at the FDA, established in 1994, plays a critical role in women s health, both within and outside the Agency, supporting sex- and gender-based research, areas in which the Society has long been a proponent. OWH provides scientific and policy expertise on sex and gender sensitive regulatory and oversight issues; endeavors to correct sex and gender disparities in the areas for which the FDA is responsible drugs, devices, and biologics; and monitors women s health priorities, providing both leadership and an integrated approach across the FDA. Despite inadequate funding, OWH provides all women with invaluable tools for their health. Each year OWH, with little difficulty, exhausts its tiny budget. OWH s pamphlets are the most requested of any documents at the government printing facility in New Mexico. Last year more than 5.6 million pamphlets are distributed to women across the Nation including target populations such as Hispanic communities, seniors and low-income citizens. Further, the Office attends over 125 meetings per year to exhibit, to present scientific posters and oral presentations, and to chair sessions. Despite its $1 million increase the office received last year, additional funding is needed so OWH may continue its present work on current projects, but expand and develop future projects. It is absolutely critical for Congress to take action now to help preserve the vital functions of OWH and to ensure that its small budget is dedicated to the resource needs of the office and to the projects and programs and research it funds. Since its beginning, OWH has funded high quality scientific research to serve as the foundation for Agency activities that improve women's health. To date, OWH has funded over 100 research projects with approximately $19.9 million intramural grants, supporting projects within the FDA that address knowledge gaps or set new directions for sex and gender research. Extramural contracts leverage a wealth of expertise and other resources outside the FDA to provide insight on regulatory questions pertinent to women s health. All contracts and grants are awarded through a competitive process. A large number of these studies are published and appear in peer reviewed journals. As part of its educational outreach efforts to consumers, OWH works closely with women's advocacy and health professional organizations to provide clarity on the results of the Women's Health Initiative. Due to OWH efforts, an informational fact sheet about menopause and hormones and a purse-sized questionnaire to review with the doctor were distributed to national and local print, radio, and Internet advertisements. OWH s website, to date, has received over three million hits to download campaign materials. May 1, 2009 SWHR 3
4 Further, OWH s website serves as a vital tool for consumers and is constantly updated to include new and important health information. The website provides free, downloadable fact sheets on over 40 different illnesses, diseases, and health related issues. Recently OWH has completed medication charts on seven chronic diseases, which are unique within the Agency. These charts list all the medications that are prescribed and available for each disease. This information is ideal for women to use in talking to their doctors, pharmacists or nurses about their treatment options. OWH continues to improve the health of women through new research initiatives. Most recently, they have collaborated with Pharmacy Choice, Inc. to create a web portal solely dedicated to FDA consumer health education materials, providing access to fact sheets and medication guides. OWH and Sex Differences Research Scientists have long known of the anatomical differences between men and women, but only within the past decade have they begun to uncover significant biological and physiological differences. Sex differences have been found everywhere from the composition of bone matter and the experience of pain, to the metabolism of certain drugs and the rate of neurotransmitter synthesis in the brain. Sex-based biology, the study of biological and physiological differences between men and women, has revolutionized the way that the scientific community views the sexes, with even more information is forthcoming as a result of the sequencing of the X chromosome. The evidence is overwhelming, and as researchers continue to find more and complex biological differences, they gain a greater understanding of the biological and physiological composition of both sexes. Much of what is known about sex differences is the result of observational studies, or is descriptive evidence from studies that were not designed to obtain a careful comparison between females and males. The Society has long recognized that the inclusion of women in study populations by itself was insufficient to address the inequities in our knowledge of human biology and medicine, and that only by the careful study of sex differences at all levels, from genes to behavior, would science achieve the goal of optimal health care for both men and women. Many sex differences are already present at birth, whereas others develop later in life. These differences play an important role in disease susceptibility, prevalence, time of onset and severity and are evident in cancer, obesity, heart disease, immune dysfunction, mental health disorders, and other illnesses. Physiological and hormonal fluctuations may also play a role in the rate of drug metabolism and effectiveness of response in females and males. This research is supported and encouraged by the Office of Women s Health within the Agency. OWH directly works with the various centers to advance the science in this area, collaborating on programs, projects, and research. Building upon sex differences research, the Society encourages the establishment of druglabeling requirements that ensure labels include language about differences experienced by women and men. Furthermore, we advocate for research on the comparative effectiveness of drugs with specific emphasis on data analysis by sex. When available, this information should be on labels. Our country's drug development process has succeeded in delivering new and better medications to ensure the health of both women and men. However, the requirement that the data acquired during research of a new drug's safety and effectiveness be analyzed as a function of sex or that information about the ways drugs may differ in various populations May 1, 2009 SWHR 4
5 (e.g., women requiring a lower dosage because of different rates of absorption or chemical breakdown) be included in prescription drug labels and other patient educational and instructional materials is generally not enforced. The Society believes the opportunity to present this information to consumers is now. Sex differences data discovered from clinical trials can be directly related to the medical community and to consumers through drug labeling and packaging inserts and other forms of alerts. As part of advancing the need to analyze and report sex differences, the Society encourages the FDA to continue adequately addressing the need for accurate drug labeling in order to identify important sex and gender differences, as well as to ensure that appropriate data analysis of post-market surveillance reporting for these differences is placed in the hands of physicians and ultimately the patient. In conclusion, Mr. Chairman, we thank you and this Committee for its strong record of support for the FDA and women s health and your commitment to OWH. We recommend that you increase the overall FY10 budget for the FDA by $386 million, so that it may dramatically improve upon current operations while also rebuilding its IT infrastructure. Secondly, we urge you to allocate $7 million for the Office of Women s Health for FY 2010, and to ensure that future budget appropriations for the OWH are never below current funding levels. We look forward to continuing to work with you to build a stronger and healthier future for all Americans. May 1, 2009 SWHR 5
I, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association
I, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association (MLA), submit this statement on behalf of MLA and the Association of Academic Health Sciences Libraries (AAHSL).
More informationMARCH OF DIMES: FISCAL YEAR 2019 FEDERAL FUNDING PRIORITIES
TESTIMONY ON BEHALF OF MARCH OF DIMES REGARDING FISCAL YEAR 2019 APPROPRIATIONS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Testimony Prepared by Cynthia Pellegrini, Senior Vice President for Public
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationApril 24, testimony. The AGS is a non-profit organization of nearly 6,000 geriatrics healthcare
AMERICAN GERIATRICS SOCIETY Written Testimony for the Record Fiscal Year 2019 Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Committee on Appropriations
More informationMarch 8, Written Testimony for FY 2018 Appropriations for the Department of Health and Human Services
AMERICAN GERIATRICS SOCIETY Written Testimony for the Record Fiscal Year 2018 Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Committee on Appropriations
More informationThe HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA)
Written Testimony for the Record to the House Subcommittee on Labor, Health and Human Services, Education and Related Agencies regarding FY 2018 Appropriations for HIV/AIDS Programs Submitted by Dr. Wendy
More informationA Blueprint for Breast Cancer Deadline 2020
A Blueprint for Breast Cancer Deadline 2020 In 1991, the National Breast Cancer Coalition was formed with one mission: an end to breast cancer. NBCC has accomplished much over its twenty plus years: bringing
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,
More informationPerspective from HHS Offices and Programs on Women s s Health: FDA Perspective
Perspective from HHS Offices and Programs on Women s s Health: FDA Perspective Kathleen Uhl, MD Assistant Commissioner for Women s s Health Office of Women s Health IOM Committee on Women s s Health Research
More informationChallenges for U.S. Attorneys Offices (USAO) in Opioid Cases
Challenges for U.S. Attorneys Offices (USAO) in Opioid Cases Overview On August 2, 2017, U.S. Attorney General Jeff Sessions announced a pilot program whereby a new federal data analysis program is being
More informationFlorida s Children First, Inc. Strategic Plan
Florida s Children First, Inc. Strategic Plan 2019-2022 November 2018 Florida s Children First, Inc. Vision Statement The Vision of Florida s Children First, Inc. is that Florida puts its children and
More informationPosition Profile Chief Executive Officer Feeding America San Diego San Diego, CA
Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA Feeding America San Diego is seeking an experienced and inspirational Chief Executive Officer to lead this impactful and
More informationStrategic Plan Executive Summary Society for Research on Nicotine and Tobacco
Strategic Plan 2013 2017 Executive Summary Society for Research on Nicotine and Tobacco Prepared By: Corona Insights Corona Insights, 2012 CoronaInsights.com CONTENTS Introduction... 1 Background... 1
More informationCenters for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC,
Centers for Disease Control and Prevention (CDC) Coalition C/o American Public Health Association 800 I Street NW Washington, DC, 20001 202-777-2514 Donald Hoppert, Director of Government Relations, American
More informationSustain and Seize Cancer Research Opportunities
One Voice Against Cancer (OVAC) appreciates the opportunity to submit written comments for the record regarding funding for cancer programs for research, prevention, detection, and treatment as well as
More informationNEW COALITION AIMS TO HELP PREVENT MISUSE, ABUSE AND DIVERSION OF ADHD MEDICATIONS Coalition to Focus Efforts on College Students
NEWS FOR IMMEDIATE RELEASE August 2014 Contact: mediainquiries@cpamm.org NEW COALITION AIMS TO HELP PREVENT MISUSE, ABUSE AND DIVERSION OF ADHD MEDICATIONS Coalition to Focus Efforts on College Students
More informationAugust 30, Washington, DC Washington, DC Dear Chairman Cochran, Chairman Blunt, Vice Chairman Leahy and Ranking Member Murray:
August 30, 2017 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman Washington, DC 20510 Washington, DC 20510 The Honorable Roy Blunt The Honorable Patty Murray Chairman Ranking
More informationOVAC FY 2017 Appropriations Requests
OVAC FY 2017 Appropriations Requests One Voice Against Cancer (OVAC), a broad coalition of cancer-related organizations representing millions of Americans, supports the goals of the Cancer Moonshot initiative
More informationJoin Today -- Be a part of something BIG that will make a difference for Oroville!
Join Today -- Be a part of something BIG that will make a difference for Oroville! In the wake of the recent evacuations in Oroville and the severe economic and reputational impact we ve seen to our community
More informationEMPOWERING WOMEN. EXPANDING AWARENESS. ERADICATING VIOLENCE.
JOIN ICADV Become a Friend today by submitting your application. Why Join ICADV? Policy Action Alerts Newsletters and Training Alerts Make a difference in the lives of survivors of domestic violence by
More information...IN BRIEF. April Larkin Street Youth Services Legislative Recommendations
Larkin Street Youth Services...IN BRIEF 2011 Legislative Recommendations Larkin Street extends its impact beyond the youth we serve by sharing our knowledge and expertise with policymakers at the local,
More informationNational Outreach Priorities & Agenda
Accreditation 2017-2018 National Outreach Priorities & Agenda ASCLD supports mandatory accreditation of forensic science service providers (FSSPs). ASCLD believes the accreditation of all FSSPs is an essential
More informationREPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine
REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH CSAPH Report 5-I-12 Subject: Presented by: Referred to: AMA Policy Consolidation: Influenza and Influenza Vaccine Sandra A. Fryhofer, MD, Chair Reference
More informationBritish Association of Stroke Physicians Strategy 2017 to 2020
British Association of Stroke Physicians Strategy 2017 to 2020 1 P age Contents Introduction 3 1. Developing and influencing local and national policy for stroke 5 2. Providing expert advice on all aspects
More informationToronto Mental Health and Addictions Supportive Housing Network TERMS OF REFERENCE
1 Toronto Mental Health and Addictions Supportive Housing Network BACKGROUND: TERMS OF REFERENCE The Toronto Mental Health and Addictions Supportive Housing Network (TMHASHN), is a network of organizations
More informationSupporting Dermatology Patients in the Digital Age. GlobalSkin White Paper January 2018
Supporting Dermatology Patients in the Digital Age GlobalSkin White Paper January 2018 Supporting Dermatology Patients in the Digital Age Contents Introduction.2 What are the challenges we need to resolve?...3
More informationWednesday, June 21, Dear Chairmen and Ranking Members:
The Honorable Rodney Frelinghuysen Committee on Appropriations 2306 Rayburn House Office Building The Honorable Tom Cole Subcommittee on Labor, Health and Human Services, Education and Related Agencies
More informationVISION» FOCUS DISCOVERY» CREATION
The Women s Health Research Institute at Northwestern University is turning possibility into reality. The possibility that we can improve women s health by requiring that all research studies put greater
More informationWellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries.
IABC Wellington: Membership Marketing work plan 2015 Context Wellington is the capital of New Zealand and its activity is centred on government, as well as the creative industries. IABC Wellington is a
More informationThe American Society of Hematology (ASH) represents more than 17,000 clinicians and
American Society of Hematology Statement to the House Appropriations Subcommittee on Labor, HHS, Education, and Related Agencies FY 2020 Funding for NIH and CDC The American Society of Hematology (ASH)
More informationTestimony by Christy Parque, President and CEO The Coalition for Behavioral Health x115
Oversight - ThriveNYC Update New York City Council Committee on Mental Health, Developmental Disability, Alcoholism Substance Abuse and Disability Services Testimony by Christy Parque, President and CEO
More informationU.S. Fund for UNICEF Campus Initiative LEADERSHIP TRANSITION HANDBOOK
U.S. Fund for UNICEF Campus Initiative LEADERSHIP TRANSITION HANDBOOK Table of Contents Introduction and Club Organization 1 Transition Guidelines 3 Sample Outgoing Officer Questionnaire 5 Sample Position
More informationUS Proposal to Transform Response to Hepatitis B and C. Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA
US Proposal to Transform Response to Hepatitis B and C Anna S. F. Lok, MD University of Michigan Ann Arbor, MI, USA US Proposal to Transform Response to Hepatitis B and C Burden of disease Deficiencies
More informationREPORT. A Model Clinical Trials System for the 21st Century
www.georgiacore.org www.georgiacancertrials.org REPORT A Model Clinical Trials System for the 21st Century A Response to the Institute of Medicine s 2010 Report A National Cancer Clinical Trials System
More informationAlex Azar Secretary, Department of Health and Human Services
February 28, 2018 Alex Azar Secretary, Department of Health and Human Services Dear Secretary Azar, On behalf of the Endocrine Society members and leaders, I write to offer our assistance as you lead the
More informationJOINT TESTIMONY. Homeless Services United Catherine Trapani Executive Director, HSU
New York City Council Committees on General Welfare and Health Oversight - Part 1: Medical Health Services in the DHS Shelter System Int. No. 929 - in relation to requiring information on health services
More informationSCAN Sponsorship Opportunities
2018-2019 SCAN Sponsorship Opportunities www.scandpg.org www.development@scandpg.org With more than 6,500 members, SCAN is the LARGEST dietetic practice group of the Academy of Nutrition and Dietetics.
More information1. Setting the Stage. 4. Priorities. 5. Strategies
A vision for PPAU 1. Setting the Stage 2. Mission 3. Vision 4. Priorities 5. Strategies 6. Plans PPFA Strategic Planning Process PPFA began a strategic planning process ten months ago that would create
More informationDEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014
DEVELOPMENTS IN THE CLINICAL TRIALS ENVIRONMENT Two Initiatives February 27, 2014 Karen Arts, Director Canadian Cancer Clinical Trial Network (3CTN) Chair of the Board of N2 Administrative Office: Lawson
More informationTestimony Submitted by: Eric Zuckerman, DO Bloomfield Hill, MI Board Chairman, Pediatric IBD Foundation
Testimony Submitted by: Carlo Di Lorenzo, MD Nationwide Children s Hospital, Columbus, OH President, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Benjamin Gold, MD, Children's
More informationVision. Mission. Hopelink s Values. Introduction. A community free of poverty
Vision A community free of poverty Mission Hopelink s mission is to promote self-sufficiency for all members of our community; we help people make lasting change. Hopelink s Values Growth and Human Potential
More informationEliminating Viral Hepatitis in Australia: Where are we in 2017?
This document was prepared by Hepatitis Australia in consultation with a variety of stakeholders working in the areas of hepatitis B and hepatitis C in Australia. This included people involved in primary
More informationThomas McLellan Velma V. Taormina William Gross Barbara Hallisey
2 Thomas McLellan, PhD, Founder and Chairman of the Board, Treatment Research Institute, former Deputy Director of the Office of National Drug Control Policy Velma V. Taormina, MD MSE FACOG, Medical Director,
More informationPriority Area: 1 Access to Oral Health Care
If you are unable to attend one of the CHARTING THE COURSE: Developing the Roadmap to Advance Oral Health in New Hampshire meetings but would like to inform the Coalition of activities and services provided
More informationDISCOVER THE BENEFITS OF MEMBERSHIP
Join us. DISCOVER THE BENEFITS OF MEMBERSHIP What's In it For You? Over 200 member organizations enjoy benefits through membership in the California Transit Association. We encourage you to join our expanding
More informationAlberta s Fire/Search and Rescue Safety Strategy
Alberta s Fire/Search and Rescue Safety Strategy A Plan for the Office of the Fire Commissioner MANDATE As the province s fire safety authority, Alberta s Office of the Fire Commissioner (OFC) engages
More informationAssociate Board Description Sheet
The Night Ministry (TNM) is a Chicago-based organization that works to provide housing, health care and human connection to members of our community struggling with poverty or homelessness. The Night Ministry
More informationWashington, DC Washington, DC Washington, DC Washington, DC 20510
March 12, 2018 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman Committee on Appropriations Committee on Appropriations Washington, DC 20510 Washington, DC 20510 The Honorable
More informationNutrition and Physical Activity Situational Analysis
Nutrition and Physical Activity Situational Analysis A Resource to Guide Chronic Disease Prevention in Alberta Executive Summary December 2010 Prepared by: Alberta Health Services, AHS Overview Intrinsic
More informationCleveland County Asthma Coalition History. The Cleveland County Health Department received a grant for Preventing and Controlling
Cleveland County Asthma Coalition History The Cleveland County Health Department received a grant for Preventing and Controlling Childhood Asthma from the Asthma Program, Women and Children s Health Section,
More informationTESTIMONY U.S. HOUSE OF REPRESENTATIVES COMMITTEE ON VETERANS 1 AFFAIRS SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS
TESTIMONY U.S. HOUSE OF REPRESENTATIVES COMMITTEE ON VETERANS 1 AFFAIRS SUBCOMMITTEE ON OVERSIGHT AND INVESTIGATIONS PUBLIC HEARING ON ELDERLY VETERANS APRIL 13. 1989 Richard C. Adelman, Ph.D. Chairman,
More informationConsultation on Legislative Options for Assisted Dying
Consultation on Legislative Options for Assisted Dying A submission to the External Panel by the Canadian Hospice Palliative Care Association October 9, 2015 Sharon Baxter Executive Director Sbaxter@bruyere.org
More informationCancer prevention and control in the context of an integrated approach
SEVENTIETH WORLD HEALTH ASSEMBLY A70/32 Provisional agenda item 15.6 13 April 2017 Cancer prevention and control in the context of an integrated approach Report by the Secretariat 1. In January 2017, the
More information2018 Candidate Guide. Leading in the fight to end Alzheimer's
2018 Candidate Guide Leading in the fight to end Alzheimer's Table of Contents Candidate Letter...2 2018 Alzheimer's Disease Facts and Figures...3 Federal Policies to Lead on Alzheimer's...4 State Policies
More informationSuraj Madoori, Treatment Action Group, U.S. and Global Health Policy Director. On behalf of the Tuberculosis Roundtable
United States House of Representatives Committee on Appropriations Subcommittee on State and Foreign Operations and Related Programs Fiscal Year 2020 Written Testimony Suraj Madoori, Treatment Action Group,
More informationANNUAL REPORT 2014 FINDING CONNECTIONS FINDING A CURE
ANNUAL REPORT 2014 FINDING CONNECTIONS FINDING A CURE FEBRUARY 1, 2013 TO JANUARY 31, 2014 MESSAGE FROM OUR LEADERSHIP For all of us, motor neurons, and the connections they make between the brain and
More informationComprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP
Comprehensive Cancer Control Technical Assistance Training and Communication Plan PI: Mandi Pratt-Chapman, MA Cooperative Agreement #1U38DP004972-01 July 2014 Acknowledgement: This work was supported by
More informationDecember 18, Submitted Electronically
December 18, 2017 Seema Verma, Administrator Centers for Medicare & Medicaid Services Department of Health and Human Services Attn: CMS-4182-P PO Box 8013 Baltimore, MD 21244-8013 Submitted Electronically
More informationChampioning patients every step of the way
Championing patients every step of the way The majority of people living with a rare disease have no treatment for their condition. At Shire, we have long believed we have a unique opportunity to champion
More informationPARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN Learn. Connect. Advocate. Partners for a Hunger-Free Oregon. Ending hunger before it begins.
Learn. Connect. Advocate. PARTNERS FOR A HUNGER-FREE OREGON STRATEGIC PLAN 2016-18 Partners for a Hunger-Free Oregon Ending hunger before it begins. Dear Partners, This has been a year of celebration,
More informationStrategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations. Emily McCloskey USCA October 3, 2014
Strategies to Improve Viral Hepatitis Prevention, Care and Treatment through Appropriations Emily McCloskey USCA October 3, 2014 About NASTAD NASTAD is an international non-profit association of U.S. state
More informationAWARD DESCRIPTION AND APPLICATION PACKAGE
AWARD DESCRIPTION AND APPLICATION PACKAGE Award Description Recipient: a graduating student from a Canadian School of Pharmacy Purpose: The purpose of this award is to recognize a graduating student who
More informationAgenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK
Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,
More informationWisconsin Office of Rural Health Rural Communities Grant Program APPLICATION COVER SHEET -- Attachment A
Wisconsin Office of Rural Health Rural Communities Grant Program 2014-15 Project Title: Planning for Healthier Lifestyles in Polk County Planning Proposal: X APPLICATION COVER SHEET -- Attachment A Implementation
More informationIntegrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs
Integrating Hepatitis Services into HIV Programs: Working Together to Meet Community Needs Chris Taylor, Senior Director, Viral Hepatitis United States Conference on AIDS: Hepatitis Pathway September 10,
More informationProgram Priorities 2018
Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term
More informationAssociation of American Cancer Institutes
Association of American Cancer Institutes Statement by the Association of American Cancer Institutes on Fiscal Year (FY) 2016 Appropriations for the Department of Health and Human Services Subcommittee
More informationRisk Classification Modeling to Combat Opioid Abuse
Risk Classification Modeling to Combat Opioid Abuse Improve Data Sharing to Identify High-Risk Prescribers of Opioids Christopher Sterling Chief Statistician NCI, Inc. www.nciinc.com 11730 Plaza America
More informationGeneration Rx: The Abuse of Prescription and Over-the-Counter Drugs
Subcommittee Hearing Statement Generation Rx: The Abuse of Prescription and Over-the-Counter Drugs United States Senate Committee on the Judiciary Subcommittee on Crime and Drugs and The Senate Caucus
More informationWe are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve.
We are a network of successful REALTORS, advancing women as professionals and leaders in business, the industry and the communities we serve. Dear Business Professional: It is a pleasure to invite you
More informationADVOCATING FOR PATIENTS WITH DIABETES
ADVOCATING FOR PATIENTS WITH DIABETES February 9, 2018 Lashawn Mciver, MD, MPH Senior vice president Government affairs & advocacy Overview 1) Highlight 2017 Advocacy Accomplishments 2) Outline 2018 Advocacy
More informationIDA and the concept of essential drugs
International Journal of Risk & Safety in Medicine 12 (1999) 75 77 75 IOS Press IDA and the concept of essential drugs Hans V. Hogerzeil Medical Officer, WHO Department of Essential Drugs and Other Medicines,
More informationAMERICA S HEALTH CARE SAFETY NET
HEALTH RESOURCES AND SERVICES ADMINISTRATION AMERICA S HEALTH CARE SAFETY NET April 7, 2015 HRSA Overview Vision statement: Healthy Communities, Healthy People Mission statement: Improve health and achieve
More informationEvaluating Communications and Outreach
Evaluating Communications and Outreach Contents Why Evaluate?...1 What Should Be Measured?...1 How Do I Get Started?...3 How Can I Analyze the Results?...4 What Do I Do with the Evaluation Findings?...5
More informationSPONSORSHIP OPPORTUNITIES
2018 SPONSORSHIP OPPORTUNITIES Our region has led the nation in showing how collaboration can make us more effective as advocates, as funders, and as developers, and at the heart of that leadership is
More informationSTATEMENT OF THE FRIENDS OF INDIAN HEALTH TO THE SUBCOMMITTEE ON INTERIOR, ENVIRONMENT, AND RELATED AGENCIES
STATEMENT OF THE FRIENDS OF INDIAN HEALTH TO THE SUBCOMMITTEE ON INTERIOR, ENVIRONMENT, AND RELATED AGENCIES COMMITTEE ON APPROPRIATIONS U.S. HOUSE OF REPRESENTATIVES ON INDIAN HEALTH SERVICE APPROPRIATIONS
More information2017 Rural Health Network Summit
2017 Rural Health Network Summit The Role of Networks in the Changing Health Care Landscape September 2017 Minneapolis, MN 525 South Lake Avenue, Suite 320 Duluth, Minnesota 55802 (218) 727-9390 info@ruralcenter.org
More informationFifth report of Committee A
SIXTY-EIGHTH WORLD HEALTH ASSEMBLY (Draft) A68/73 26 May 2015 Fifth report of Committee A (Draft) Committee A held its twelfth and thirteenth meetings on 25 May 2015 under the chairmanship of Dr Eduardo
More informationRAPID DIAGNOSIS AND TREATMENT OF MDR-TB
RAPID DIAGNOSIS AND TREATMENT OF MDR-TB FORMING PARTNERSHIPS TO STRENGTHEN THE GLOBAL RESPONSE TO MDR-TB - WHERE IT MATTERS MOST I am delighted that this initiative will improve both the technology needed
More informationTestimony of Mr. David Guth, CEO, Centerstone America. Combating the Opioid Crisis:
Testimony of Mr. David Guth, CEO, Centerstone America House of Representatives Committee on Energy and Commerce Hearing Subcommittee on Health: Combating the Opioid Crisis: Improving the Ability of Medicare
More informationSPONSORSHIP OPPORTUNITIES
SPONSORSHIP OPPORTUNITIES 2018 WHAT IS HYDROCEPHALUS? Hydrocephalus is caused by an imbalance in the production and absorption of cerebral spinal fluid in the brain which causes the ventricles to enlarge.
More informationRICHLAND COUNTY MENTAL HEALTH AND RECOVERY SERVICES
RICHLAND COUNTY MENTAL HEALTH AND RECOVERY SERVICES 5-YEAR STRATEGIC PLAN SUMMARY 2017 TO 2022 Mission Statement The mission of the Richland County Mental Health and Recovery Services Board is to facilitate
More informationPrincipal actions to date:
American Academy of Neurology American Headache Society Headache Cooperative of New England Headache Cooperative of the Pacific Migraine Research Foundation Miles for Migraine National Headache Foundation
More informationEpilepsy Foundation North/ Central Illinois. FY19-FY21 3 year Strategic Plan 20 June 2018
Epilepsy Foundation North/ Central Illinois FY19-FY21 3 year Strategic Plan 20 June 2018 Strategic Plan Overview The reason we exist is to bring hope where there is none Help connect people with resources
More informationDental Public Health Activities & Practices
Dental Public Health Activities & Practices Practice Number: 16005 Submitted By: Division of Oral Health, Illinois Department of Public Health Oral Health Submission Date: April 2002 Last Updated: October
More informationFebruary 13, The Honorable Fred Upton 2183 Rayburn House Office Building Washington, DC Dear Chairman Upton:
NATIONAL OFFICE Advocacy and Access Department 1615 L Street, NW #320 Washington, DC 20036 February 13, 2015 The Honorable Fred Upton 2183 Rayburn House Office Building Washington, DC 20515 Dear Chairman
More informationThe Academy Capitol Forum: Meet the Experts. Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved
The Academy Capitol Forum: Meet the Experts Diagnosing Which Health Treatments Improve Outcomes: A PCORI Overview and How to Get Involved Presenter: Gregory Martin, Deputy Directory of Stakeholder Engagement
More informationDental Public Health Activities & Practices
Dental Public Health Activities & Practices Practice Number: 37002 Submitted By: North Dakota Department of Health, Family Health Division Submission Date: January 2010 Last Updated: January 2010 SECTION
More informationSTATE AND COMMUNITY MODELS FOR IMPROVING ACCESS TO DENTAL CARE FOR THE UNDERSERVED
American Dental Association STATE AND COMMUNITY MODELS FOR IMPROVING ACCESS TO DENTAL CARE FOR THE UNDERSERVED October 2004 Executive Summary American Dental Association. State and Community Models for
More informationGuidelines for implementation of Article 14
Guidelines for implementation of Article 14 Demand reduction measures concerning tobacco dependence and cessation Adopted by the Conference of the Parties at its fourth session (decision FCTC/COP4(8))
More informationRe: Docket No. FDA D Presenting Risk Information in Prescription Drug and Medical Device Promotion
1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org August 25, 2009 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,
More informationReview of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
More informationMedical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years. Written Statement of
Medical Devices and the Public s Health: The FDA 510(k) Clearance Process at 35 Years Written Statement of Dr. David R. Challoner Vice President for Health Affairs, Emeritus University of Florida and Chair,
More informationPolicies Affecting Our Food Environment
Policies Affecting Our Food Environment Amy L. Yaroch, Ph.D. Gretchen Swanson Center for Nutrition, Omaha, NE About Us Independent research institution providing scientific expertise, partnership and resources
More informationAmerican Diabetes Association 2017 Advocacy Priorities LaShawn McIver, MD, MPH Friday, February 17, :30 p.m. 5:15 p.m.
American Diabetes Association 2017 Advocacy Priorities LaShawn McIver, MD, MPH Friday, February 17, 2017 4:30 p.m. 5:15 p.m. Each year the American Diabetes Association establishes its legislative and
More informationNortheast Health Care Quality Foundation The QIO for Maine, New Hampshire and Vermont
The Big Picture Using the Triple Aim to Provide Affordable, Accessible, and Quality Care for Older Adults with Alzheimer s Disease and their Families October 16, 2013 This material was prepared by (NHCQF),
More informationAlthough PDMPs are separately managed and maintained by each state or jurisdiction, the national network facilitates more uniformity among states.
NASCSA Statement for the Record as presented by Barbara A Carter, President, NASCSA Submitted to: Department of Health and Human Services, Food and Drug Administration, Opioid Policy Steering Committee
More informationAlzheimer s Society. Consultation response. Our NHS care objectives: A draft mandate to the NHS Commissioning Board.
Alzheimer s Society Our NHS care objectives: A draft mandate to the NHS Commissioning Board 26 September 2012 Delivering Dignity Securing dignity in care for older people in hospitals and care homes: A
More informationBig Lottery Fund Phase II Consultation. What you told us Summary of results
Big ottery Fund Phase II Consultation What you told us Summary of results Need more information? June 2005 Visit our website at www.biglotteryfund.org.uk Copyright Big ottery Fund, 2005 Design Print Further
More informationCommunity Benefit Strategic Implementation Plan. Better together.
Community Benefit Strategic Implementation Plan 2016 2019 Better together. Table of Contents Introduction... 4 Priority 1: Community Health Infrastructure... 5 Objective 1.1: Focus resources strategically
More information